SKI Market

A+| A| A-|

Indian Indices

Sensex

78,111.24 1,263.67
( 1.64%)

Global Indices

Nasdaq

48,558.84 319.59
(0.66%)

Dow Jones

6,987.77 80.53
(1.17%)

Hang Seng

58,133.63 256.24
(0.44%)

Nikkei 225

10,572.50 -36.56
(-0.34%)

Forex

USD-INR

93.84 0.69
(0.74%)

EUR-INR

109.88 0.75
(0.69%)

GBP-INR

126.18 0.90
(0.72%)

JPY-INR

0.59 0.00
(0.59%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

90.82

396370.14

EPS(TTM)

Face Value()

Div & Yield %

18.19

0.97

Back

Satia Industries reports standalone net loss of Rs 24.52 crore in the September 2025 quarter

Nov 16,2025

Net loss of Satia Industries reported to Rs 24.52 crore in the quarter ended September 2025 as against net profit of Rs 12.33 crore during the previous quarter ended September 2024. Sales declined 8.52% to Rs 311.13 crore in the quarter ended September 2025 as against Rs 340.12 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	311.13	340.12	-9
OPM %	2.11	13.25	-
PBDT	10.22	40.82	-75
PBT	-25.12	1.25	PL
NP	-24.52	12.33	PL

78,111.24 1,263.67 ( 1.64%)

48,558.84 319.59 (0.66%)

6,987.77 80.53 (1.17%)

58,133.63 256.24 (0.44%)

10,572.50 -36.56 (-0.34%)

93.84 0.69 (0.74%)

109.88 0.75 (0.69%)

126.18 0.90 (0.72%)

0.59 0.00 (0.59%)